Amedisys Inc. (AMED) Rapporto sugli Utili - Previsioni e Surprise Ratio

Pubblicita'

Storico dei ricavi trimestrali

AMED rapporto: 82%

100%

AMED supera 28 di 34 ultime stime

Data del prossimo reportNov 5, 2024

Stimato per Q3 24:$1.14

Cambiamenti implicati per il Q2 24:-13.64%

Cambiamenti implicati per il Q3 23:+16.33%

Periodo Bilanci	Data Riportata	EPS / Previsioni	Sorpresa
Q2 24	Jul 24, 2024	$1.32 / $1.22	$0.1 / 8.2%
Q1 24	Apr 24, 2024	$1.03 / $1.01	$0.02 / 1.98%
Q4 23	Feb 21, 2024	$0.94 / $1.04	$-0.1 / -9.62%
Q3 23	Oct 24, 2023	$0.98 / $1.08	$-0.1 / -9.26%
Q2 23	Jul 26, 2023	$1.37 / $1.07	$0.3 / 28.04%
Q1 23	May 3, 2023	$1 / $0.86	$0.14 / 16.28%
Q4 22	Feb 15, 2023	$1.16 / $1.03	$0.13 / 12.62%
Q3 22	Oct 26, 2022	$1.15 / $1.24	$-0.09 / -7.26%

Fornitori di Dati: Xignite Logo